Search research articles
Contact Us
Filters
Showing results (81-90 of 671) with videos related to
Page
of 68
Sort By:
NEJM Evidence
|
February 6, 2024
Colistin - That Was Fun, But Now We're Done
Taison D Bell, Stacy C Park
NEJM Evidence
|
February 6, 2024
How Frequently Should Patients with Breast Cancer Have Routine Follow-Up Visits?
Ana-Alicia Beltran-Bless, Mark Clemons
NEJM Evidence
|
February 6, 2024
Do Anticoagulants Preserve Function and Quality of Life in Older Adults with Atrial Fibrillation?
Sachin J Shah, Kenneth E Covinsky
NEJM Evidence
|
February 6, 2024
Fossil-Fuel Pollution and Climate Change - A New NEJM Group Series
Caren G Solomon, Renee N Salas, Debra Malina, et al.
NEJM Evidence
|
February 6, 2024
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
Alexander M M Eggermont, Michal Kicinski, Christian U Blank, et al.
NEJM Evidence
|
February 6, 2024
Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities
Arnon P Kater, Carolyn Owen, Carol Moreno, et al.
NEJM Evidence
|
February 6, 2024
Behind the Scenes of TOPCAT - Bending to Inform
Marc A Pfeffer, Brian Claggett
NEJM Evidence
|
February 6, 2024
Randomized Phase I Trials - One Size Fits All?
Susan Halabi, Codruta Chiuzan
NEJM Evidence
|
February 6, 2024
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine Trials
Sally Hunsberger, Susan S Ellenberg, Steven Joffe, et al.
NEJM Evidence
|
February 6, 2024
Can the Heart Get an Overuse Sports Injury?
Paul D Thompson, Thijs M H Eijsvogels, Jonathan H Kim
Page
of 68
Search research articles
Search
Showing results (81-90 of 671) with videos related to
Sort By:
Page
of 68
NEJM Evidence
|
February 6, 2024
Colistin - That Was Fun, But Now We're Done
Taison D Bell, Stacy C Park
NEJM Evidence
|
February 6, 2024
How Frequently Should Patients with Breast Cancer Have Routine Follow-Up Visits?
Ana-Alicia Beltran-Bless, Mark Clemons
NEJM Evidence
|
February 6, 2024
Do Anticoagulants Preserve Function and Quality of Life in Older Adults with Atrial Fibrillation?
Sachin J Shah, Kenneth E Covinsky
NEJM Evidence
|
February 6, 2024
Fossil-Fuel Pollution and Climate Change - A New NEJM Group Series
Caren G Solomon, Renee N Salas, Debra Malina, et al.
NEJM Evidence
|
February 6, 2024
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
Alexander M M Eggermont, Michal Kicinski, Christian U Blank, et al.
NEJM Evidence
|
February 6, 2024
Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities
Arnon P Kater, Carolyn Owen, Carol Moreno, et al.
NEJM Evidence
|
February 6, 2024
Behind the Scenes of TOPCAT - Bending to Inform
Marc A Pfeffer, Brian Claggett
NEJM Evidence
|
February 6, 2024
Randomized Phase I Trials - One Size Fits All?
Susan Halabi, Codruta Chiuzan
NEJM Evidence
|
February 6, 2024
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine Trials
Sally Hunsberger, Susan S Ellenberg, Steven Joffe, et al.
NEJM Evidence
|
February 6, 2024
Can the Heart Get an Overuse Sports Injury?
Paul D Thompson, Thijs M H Eijsvogels, Jonathan H Kim
Page
of 68